Elsulfavirine
Sponsors
Viriom
Conditions
Covid19HIV-1-infection
Phase 1
An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy Volunteers
CompletedNCT05148754
Start: 2021-01-23End: 2021-08-16Updated: 2021-12-09
Study of Single Ascending Doses of Elsulfavirine to Evaluate the Safety, Tolerability, and Pharmacokinetics of Elsulfavirine and Its Active Metabolite VM-1500A in Healthy Subjects
CompletedNCT05165550
Start: 2022-04-12End: 2022-07-13Updated: 2023-02-21